Home›People›Donna Padavan
Donna Padavan

Donna Padavan

VP Clinical & Regulatory Affairs, Founder, director at Rose Diagnostics.

ExecutiveDirector
Updated Nov 9, 2026·Latest SEC filing Sep 15, 2026·Suggest an edit

About Donna Padavan

Donna Padavan is VP Clinical & Regulatory Affairs, Founder, director at Rose Diagnostics.

Donna Padavan first appears on SEC filings in 2024.

Experience

This experience comes from Donna Padavan's profile and from SEC filings. For roles taken from filings, the years are when the filings name Donna Padavan in the role, so the role may have started earlier or lasted longer.

Rose Diagnostics Inc. Current
VP Clinical & Regulatory Affairs, Founder, director
VP Clinical and Regulatory Affairs (2023 – Present)
2023 – Present · Carlsbad, CA
Develops a rapid lung biopsy sample test for clinicians.
SQI Diagnostics
Director of Clinical Research and Development
2020 – 2023
Padovil Inc.
Biomedical Engineering Consultant
2017 – 2018
Abbott, Point of Care Division
Senior R&D Engineer, PEng, PhD
2012 – 2016
University of Ottawa Heart Institute
Fellow
2011 – 2013
Western University
Post Doctoral Associate
2005 – 2010

Key Colleagues at Startups

The people Donna Padavan works with at each company, as listed on that company's latest Form D.

Rose Diagnostics Inc. · Form D, Sep 15, 2026
Eric Brouwer
Eric Brouwer
CSO & Founder, director
Adolfo Velazquez
Adolfo Velazquez
CTO & Founder, director
PG
Paul Gold
Director
Andrew Morris
Andrew Morris
CEO & Founder, director

Sources

  1. SECRose Diagnostics Inc. Form D, filed Sep 15, 2026